ResoTher Pharma appoints Teis Vester as Chief Financial Officer
ResoTher Pharma is pleased to announce the appointment of Teis Vester, MSc., [...]
ResoTher Pharma strengthens its leadership team
ResoTher Pharma is pleased to announce the following changes to its leadership [...]
ResoTher Pharma announces changes to its Board of Directors
ResoTher Pharma ApS, Holte, Denmark, announces today that the shareholders has elected [...]
ResoTher Pharma announces capital raise of DKK 38.8M
Press release: ResoTher Pharma ApS, a Danish biotech company, today announces the [...]
ResoTher Pharma R&D update
ResoTher Pharma is pleased to announce that we have completed IND-enabling toxicology [...]
Anthony Mathur, MD joins our Scientific Advisory Board
ResoTher Pharma is pleased to announce the addition of Dr Anthony Mathur [...]
ResoTher Pharma appoints Teis Vester as Chief Financial Officer
ResoTher Pharma is pleased to announce the appointment of Teis [...]
ResoTher Pharma strengthens its leadership team
ResoTher Pharma is pleased to announce the following changes to [...]
ResoTher Pharma announces changes to its Board of Directors
ResoTher Pharma ApS, Holte, Denmark, announces today that the shareholders [...]
ResoTher Pharma announces capital raise of DKK 38.8M
Press release: ResoTher Pharma ApS, a Danish biotech company, today [...]
ResoTher Pharma R&D update
ResoTher Pharma is pleased to announce that we have completed [...]
Anthony Mathur, MD joins our Scientific Advisory Board
ResoTher Pharma is pleased to announce the addition of Dr [...]